Effect of 90-yttrium-Ibritumomab Tiuxetan in patients with Non-Hodgkin Lymphoma
Latest Information Update: 13 May 2015
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Rituximab
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
Most Recent Events
- 13 May 2015 New trial record